RIM
AGN

Rainier Investment Management’s Allergan Inc AGN Stock Holding History

Rainier Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-52,718
Closed -$11.2M – 219
2014
Q4 		$11.2M Sell
52,718
-376,010
-88% -$74.8M 0.2% 146
2014
Q3 		$76.4M Buy
428,728
+96,840
+29% +$16.1M 1.27% 12
2014
Q2 		$56.2M Sell
331,888
-369,017
-53% -$57.5M 0.87% 36
2014
Q1 		$87M Sell
700,905
-157,780
-18% -$19.2M 1.04% 28
2013
Q4 		$95.4M Sell
858,685
-136,680
-14% -$13.1M 0.99% 31
2013
Q3 		$90M Sell
995,365
-269,015
-21% -$24.1M 0.87% 36
2013
Q2 		$107M Buy
+1,264,380
New +$131M 0.96% 17

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Rainier Investment Management's AGN Position: Q1 2015 in Review

Rainier Investment Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 52,718 shares — an estimated $11.2M sold.

Rainier Investment Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $107M in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Rainier Investment Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Rainier Investment Management sold 52,718 Allergan Inc shares in Q1 2015, an estimated $11.2M.
  • Rainier Investment Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Rainier Investment Management's Allergan Inc position peaked at $107M in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Rainier Investment Management's 13F filing for Q1 2015, filed 15 May 2015.